The GTH — Gesellschaft für Thrombose– und Hämostaseforschung e.V. is delighted to invite you to the 58th Annual Meeting of the GTH to be held February 12 – 15, 2014, in Vienna, Austria.
In an effort to highlight the translational approach of this meeting we will aim to connect basic research with clinical applications in all areas covered. Therefore we plan to open clinical sessions with a lecture devoted to basic research and vice versa we plan to have a clinical lecture concluding basic research sessions. A strong focus will also be laid on the work of young researchers who will be able to present their results in oral sessions as well as in interactive moderated poster sessions.
It should also be emphasized that Vienna, like not many other big cities in Europe, offers a wide range of cultural highlights and leisure activities to be enjoyed after a demanding day at the meeting. We hope that we could raise your interest with our planned scientific activities and we look forward to welcome you in February 2014 at the 58th Annual Meeting of the GTH in Vienna.
Awards and Prizes
The following prizes will be awarded at the 58th Annual Meeting of the Society of Thrombosis and Haemostasis Research (GTH) in Vienna, Austria:
- Alexander-Schmidt-Award for excellent reasearch studies in the field of haemostaseology
- Award for young researchers for excellent research of young scientists
- Hans-Engli-Research Grant four young physicians for a 6-month research project on congenital blood diseases
- Rudolf-Marx-Grant for young scientists from German-speaking countries
For detailed information and terms of application please consult the GTH website www.gth-online.org. Applications should be submitted electronically (pdf document) to the GTH administration office no later than November 30, 2013. Please include your phone and fax number as well as the name of the prize in your application.
Abstracts can be submitted to the following topics:
- Aging and Thrombosis
- Arterial Thrombosis
- Arterial and Venous Thrombosis – Communalities and Differences
- Pulmonary Embolism
- Venous Thrombosis
- Acute Coronary Syndromes
- Atrial Fibrillation
- Cerebrovascular Disease
- Coagulation and Vascular Patency
- Peripheral Artery Disease
Thrombosis and Haemostasis beyond Cardiovascular Disease
- Autoimmune Diseases and Thrombosis
- Cancer and Thrombosis
- Dysfunctional Angiogenesis
- Haemostasis, Pregnancy and Obstetrics
- Pediatrics and Thrombosis
Diabetes and Metabolic Disorders and Thrombosis
- Diabetic Vascular Complications
- Metabolic Syndrome, Diabetes and Thrombosis
- Nutrition, Obesity and Haemostasis
Infection, Inflammation and Thrombosis
- Leucocytes and Haemostasis
- Monocyte Subtypes in Cardiovascular Disease
- Microbiome & Thrombosis
- Infection, Inflammation and Thrombotic Events
Laboratory Issues and Models of Thrombosis
- Animal Models of Thrombosis Anticoagulants
- Novel Agents and Test Principles
- Platelet Function Testing
Haemorrhagic Diathesis and Coagulation Factors
- ADAMST13/von Willebrand Factor
- Bleeding Disorders
- Factor XIII
- Tissue Factor
- Platelet Aspects
- Platelet Concentrates and Transfusion Medicine
- Antiplatelet Agents
- Perioperative Bridging
- Pharmacogenetics and Drug Interactions
- Role of Antibodies in Blood Coagulation
- Theragnostic Approach in Posttraumatic Coagulopathy
New Issues and Developments in Thrombosis and Haemostasis
- Genomics, Proteomics and Metabolomics
- Nucleic Acids and Thrombosis
- Stem Cells
Authors may indicate their preferred presentation type (free paper or poster presentations), the final decision in regards to the presentation type will however be taken by the Scientific Committee. Submission of an abstract constitutes a commitment by the author to present at the congress if accepted.
Abstracts may be submitted in English only. Please make sure that special characters and symbols are inserted correctly through the toolbar provided. Authors will be able to draft the abstracts online and may return to the site to edit the texts of the abstracts if necessary.
A highly qualified panel of reviewers will assess all submitted abstracts. Abstracts will be approved according to their scientific/clinical merit.
Notification of acceptance and information regarding presentations will be forwarded to the authors immediately after the reviewing process by e-mail (approximately end of November 2013). If an abstract is accepted it is mandatory for the presenting author to attend the congress.
For an abstract to be included in the final scientific program, it is mandatory for the presenting author to register for the congress and to settle payment as soon as the notification of abstract acceptance is received and not later than Thursday, December 12, 2013.
Abstracts will be published in a supplement of the Journal Hämostaseologie as they have been received.